Rocket Lab stock rebounds as Neutron test rupture hangs over 2026 debut
Rocket Lab shares rose 3.1% to $90.72 by late Friday morning after a Stage 1 tank rupture during Neutron rocket testing raised concerns about launch delays. The company is reviewing test data to assess impacts on its schedule, with an update expected during its February earnings call. Director Jon A. Olson sold 15,205 shares on Jan. 20, retaining 345,630. Rocket Lab completed its 80th Electron launch this week.